- Report
- October 2024
- 193 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 89 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- February 2025
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2025
- 184 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 194 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- May 2024
- 128 Pages
Global
From €2815EUR$2,950USD£2,359GBP
- Report
- July 2024
- 80 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2023
North America
From €1432EUR$1,500USD£1,199GBP
- Book
- September 2024
- 624 Pages
- Book
- August 2022
- 640 Pages
- Book
- September 2013
- 480 Pages
- Book
- April 2010
- 560 Pages

The Human Biology market within the context of Biotechnology is focused on the development of products and services that improve human health. This includes the development of drugs, diagnostics, medical devices, and other treatments. It also includes research into the genetic and molecular basis of human diseases, as well as the development of new technologies to diagnose and treat them. The Human Biology market is a rapidly growing sector of the biotechnology industry, with many companies investing heavily in research and development.
The Human Biology market is highly competitive, with many companies vying for a share of the market. Companies in this market are typically focused on developing innovative products and services that can improve human health. These companies often collaborate with universities, research institutes, and other organizations to develop new technologies and treatments.
Some of the major companies in the Human Biology market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more